Pretraga

Pretražite po imenu i prezimenu autora, mentora, urednika, prevoditelja

Napredna pretraga

Pregled bibliografske jedinice broj: 1110971

More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments

Kandolf Sekulovic, L.; Peris, K.; Hauschild, A.; Stratigos, A.; Grob, J.-J.; Nathan, P.; Dummer, R.; Forsea, A.-M.; Hoeller, C.; Gogas, H. et al.
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments // European journal of cancer (1990), 75 (2017), 313-322 doi:10.1016/j.ejca.2017.01.012 (međunarodna recenzija, članak, znanstveni)

CROSBI ID: 1110971 Za ispravke kontaktirajte CROSBI podršku putem web obrasca

Naslov
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments
(More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments)

Autori
Kandolf Sekulovic, L. ; Peris, K. ; Hauschild, A. ; Stratigos, A. ; Grob, J.-J. ; Nathan, P. ; Dummer, R. ; Forsea, A.-M. ; Hoeller, C. ; Gogas, H. ; Demidov, L. ; Lebbe, C. ; Blank, C. ; Olah, J. ; Bastholt, L. ; Herceg, Davorin ; Neyns, B. ; Vieira, R. ; Hansson, J. ; Rutkowski, P. ; Krajsova, I. ; Bylaite-Bucinskiene, M. ; Zalaudek, I. ; Marić- Brozić, Jasmina ; Babovic, N. ; Banjin, M. ; Putnik, K. ; Weinlich, G. ; Todorovic, V. ; Kirov, K. ; Ocvirk, J. ; Zhukavets, A. ; Kukushkina, M. ; De La Cruz Merino, L. ; Ymeri, A. ; Risteski, M. ; Garbe, C.

Izvornik
European journal of cancer (1990) (0959-8049) 75 (2017); 313-322

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
access ; innovative medicines ; metastatic melanoma ; treatment ; immunooncologytargeted therapyhealth expenditure per capita ; human development index

Sažetak
Despite the efficacy of innovative treatments for metastatic melanoma, their high costs has led to disparities in cancer care among different European countries. We analysed the availability of these innovative therapies in Europe and estimated the number of patients without access to first-line recommended treatment per current guidelines of professional entities such as the European Society for Medical Oncology (ESMO), the European Organisation for Research and Treatment of Cancer (EORTC), the European Association of Dermato-Oncology (EADO), and European Dermatology Forum (EDF).

Izvorni jezik
Engleski

Znanstvena područja
Kliničke medicinske znanosti



POVEZANOST RADA

Ustanove:
Stomatološki fakultet, Zagreb,
Klinički bolnički centar Zagreb

Profili:

Avatar Url Jasmina Marić Brozić (autor)

Avatar Url Davorin Herceg (autor)

Poveznice na cjeloviti tekst rada:

doi www.sciencedirect.com

Citiraj ovu publikaciju:

Kandolf Sekulovic, L.; Peris, K.; Hauschild, A.; Stratigos, A.; Grob, J.-J.; Nathan, P.; Dummer, R.; Forsea, A.-M.; Hoeller, C.; Gogas, H. et al.
More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments // European journal of cancer (1990), 75 (2017), 313-322 doi:10.1016/j.ejca.2017.01.012 (međunarodna recenzija, članak, znanstveni)
Kandolf Sekulovic, L., Peris, K., Hauschild, A., Stratigos, A., Grob, J., Nathan, P., Dummer, R., Forsea, A., Hoeller, C. & Gogas, H. (2017) More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. European journal of cancer (1990), 75, 313-322 doi:10.1016/j.ejca.2017.01.012.
@article{article, author = {Kandolf Sekulovic, L. and Peris, K. and Hauschild, A. and Stratigos, A. and Grob, J.-J. and Nathan, P. and Dummer, R. and Forsea, A.-M. and Hoeller, C. and Gogas, H. and Demidov, L. and Lebbe, C. and Blank, C. and Olah, J. and Bastholt, L. and Herceg, Davorin and Neyns, B. and Vieira, R. and Hansson, J. and Rutkowski, P. and Krajsova, I. and Bylaite-Bucinskiene, M. and Zalaudek, I. and Mari\'{c}- Brozi\'{c}, Jasmina and Babovic, N. and Banjin, M. and Putnik, K. and Weinlich, G. and Todorovic, V. and Kirov, K. and Ocvirk, J. and Zhukavets, A. and Kukushkina, M. and De La Cruz Merino, L. and Ymeri, A. and Risteski, M. and Garbe, C.}, year = {2017}, pages = {313-322}, DOI = {10.1016/j.ejca.2017.01.012}, keywords = {access, innovative medicines, metastatic melanoma, treatment, immunooncologytargeted therapyhealth expenditure per capita, human development index}, journal = {European journal of cancer (1990)}, doi = {10.1016/j.ejca.2017.01.012}, volume = {75}, issn = {0959-8049}, title = {More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments}, keyword = {access, innovative medicines, metastatic melanoma, treatment, immunooncologytargeted therapyhealth expenditure per capita, human development index} }
@article{article, author = {Kandolf Sekulovic, L. and Peris, K. and Hauschild, A. and Stratigos, A. and Grob, J.-J. and Nathan, P. and Dummer, R. and Forsea, A.-M. and Hoeller, C. and Gogas, H. and Demidov, L. and Lebbe, C. and Blank, C. and Olah, J. and Bastholt, L. and Herceg, Davorin and Neyns, B. and Vieira, R. and Hansson, J. and Rutkowski, P. and Krajsova, I. and Bylaite-Bucinskiene, M. and Zalaudek, I. and Mari\'{c}- Brozi\'{c}, Jasmina and Babovic, N. and Banjin, M. and Putnik, K. and Weinlich, G. and Todorovic, V. and Kirov, K. and Ocvirk, J. and Zhukavets, A. and Kukushkina, M. and De La Cruz Merino, L. and Ymeri, A. and Risteski, M. and Garbe, C.}, year = {2017}, pages = {313-322}, DOI = {10.1016/j.ejca.2017.01.012}, keywords = {access, innovative medicines, metastatic melanoma, treatment, immunooncologytargeted therapyhealth expenditure per capita, human development index}, journal = {European journal of cancer (1990)}, doi = {10.1016/j.ejca.2017.01.012}, volume = {75}, issn = {0959-8049}, title = {More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments}, keyword = {access, innovative medicines, metastatic melanoma, treatment, immunooncologytargeted therapyhealth expenditure per capita, human development index} }

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Science Citation Index Expanded (SCI-EXP)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE

Citati:

    Altmetrijski pokazatelji:


    Podijeli:





    Contrast
    Increase Font
    Decrease Font
    Dyslexic Font
    CROSBI koristi kolačiće (cookies) kako bi poboljšao funkcionalnost stranice.